Literature DB >> 12728312

Hyaluronan is not elevated in urine or serum in Hutchinson-Gilford Progeria Syndrome.

Leslie B Gordon1, Ingrid A Harten, Anthony Calabro, Geetha Sugumaran, Antonei B Csoka, W Ted Brown, Vincent Hascall, Bryan P Toole.   

Abstract

Elevations in urinary hyaluronan have been used as the principal laboratory indicator for diagnosis of Hutchinson-Gilford Progeria Syndrome (HGPS). Previous reports have provided evidence suggesting that children with HGPS have altered hyaluronan metabolism as indicated by a mean 17-fold increase in urinary hyaluronan over normal values. In addition, adults with Werner's syndrome have elevated urinary hyaluronan and even more prominent elevations in serum hyaluronan over age-matched controls. It is not known whether serum hyaluronan is elevated or whether serum hyaluronan levels correlate with urinary hyaluronan levels in children with HGPS. In a large cohort of 19 HGPS patients, we sought to confirm elevations in urinary hyaluronan concentration, to establish whether serum hyaluronan is elevated, to measure the size of urinary hyaluronan, and to determine whether serum or urine hyaluronidase levels are altered. We have analyzed urinary and serum hyaluronan levels in patients with HGPS and control patients (1) by using an enzyme-linked immunosorbent assay (ELISA)-like method in which sample hyaluronan in solution and hyaluronan in solid phase compete for a solution of biotinylated hyaluronan-binding protein, and (2) by fluorophore-assisted carbohydrate electrophoresis. The size of urinary hyaluronan was measured by using Sepharose CL-6B size exclusion chromatography. Serum and urinary hyaluronidases were evaluated quantitatively, by using ELISA, and qualitatively, by using a gel detection method. HGPS patients did not show a significant elevation in either urinary or serum hyaluronan. We detected no difference in the size of urinary hyaluronan between HGPS children and age-matched controls. Serum and urinary hyaluronidase levels were not significantly different in normal and HGPS patients. These studies indicate that neither serum nor urinary hyaluronan concentration is a reliable diagnostic or prognostic marker for HGPS and underscore a difference between adult and childhood progerias.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12728312     DOI: 10.1007/s00439-003-0958-9

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  52 in total

Review 1.  Hyaluronan-cell interactions in cancer and vascular disease.

Authors:  Bryan P Toole; Thomas N Wight; Markku I Tammi
Journal:  J Biol Chem       Date:  2001-11-20       Impact factor: 5.157

2.  Aliphatic ammonium salts in the assay of acidic polysaccharides from tissues.

Authors:  J E SCOTT
Journal:  Methods Biochem Anal       Date:  1960

Review 3.  Progeria.

Authors:  A J Badame
Journal:  Arch Dermatol       Date:  1989-04

4.  Increased elastin production by progeria skin fibroblasts is controlled by the steady-state levels of elastin mRNA.

Authors:  G C Sephel; A Sturrock; M G Giro; J M Davidson
Journal:  J Invest Dermatol       Date:  1988-05       Impact factor: 8.551

5.  Analysis by high-performance liquid chromatography of hyaluronic acid and chondroitin sulfates.

Authors:  M E Zebrower; F J Kieras; W T Brown
Journal:  Anal Biochem       Date:  1986-08-15       Impact factor: 3.365

6.  A method for the quantitation of hyaluronan (hyaluronic acid) in biological fluids using a labeled avidin-biotin technique.

Authors:  P Kongtawelert; P Ghosh
Journal:  Anal Biochem       Date:  1990-03       Impact factor: 3.365

7.  Elevation of serum hyaluronan level in Werner's syndrome.

Authors:  M Tanabe; M Goto
Journal:  Gerontology       Date:  2001 Mar-Apr       Impact factor: 5.140

8.  Hyaluronuria in a case of progeria. (Hutchinson-Gilford syndrome).

Authors:  M Tokunaga; E Wakamatsu; K Sato; S Satake; K Aoyama; K Saito; M Sugawara; Z Yosizawa
Journal:  J Am Geriatr Soc       Date:  1978-07       Impact factor: 5.562

9.  Purification and characterization of human serum hyaluronidase.

Authors:  A M Afify; M Stern; M Guntenhöner; R Stern
Journal:  Arch Biochem Biophys       Date:  1993-09       Impact factor: 4.013

10.  Hyaluronate in suction blisters from patients with scleroderma and various skin disorders.

Authors:  L Juhlin; A Tengblad; J P Ortonne; J P Lacour
Journal:  Acta Derm Venereol       Date:  1986       Impact factor: 4.437

View more
  11 in total

1.  Stromal hyaluronan interaction with epithelial CD44 variants promotes prostate cancer invasiveness by augmenting expression and function of hepatocyte growth factor and androgen receptor.

Authors:  Shibnath Ghatak; Vincent C Hascall; Roger R Markwald; Suniti Misra
Journal:  J Biol Chem       Date:  2010-03-03       Impact factor: 5.157

2.  Cooperative roles for emmprin and LYVE-1 in the regulation of chemoresistance for primary effusion lymphoma.

Authors:  Z Qin; L Dai; M Bratoeva; M G Slomiany; B P Toole; C Parsons
Journal:  Leukemia       Date:  2011-06-10       Impact factor: 11.528

3.  Inhibition of Functional Hyaluronan-CD44 Interactions in CD133-positive Primary Human Ovarian Carcinoma Cells by Small Hyaluronan Oligosaccharides.

Authors:  Mark G Slomiany; Lu Dai; Lauren B Tolliver; G Daniel Grass; Yiping Zeng; Bryan P Toole
Journal:  Clin Cancer Res       Date:  2009-12-15       Impact factor: 12.531

4.  CD147, CD44, and the epidermal growth factor receptor (EGFR) signaling pathway cooperate to regulate breast epithelial cell invasiveness.

Authors:  G Daniel Grass; Lauren B Tolliver; Momka Bratoeva; Bryan P Toole
Journal:  J Biol Chem       Date:  2013-07-25       Impact factor: 5.157

5.  Aberrant splice variants of HAS1 (Hyaluronan Synthase 1) multimerize with and modulate normally spliced HAS1 protein: a potential mechanism promoting human cancer.

Authors:  Anirban Ghosh; Hemalatha Kuppusamy; Linda M Pilarski
Journal:  J Biol Chem       Date:  2009-05-18       Impact factor: 5.157

6.  Abrogating drug resistance in malignant peripheral nerve sheath tumors by disrupting hyaluronan-CD44 interactions with small hyaluronan oligosaccharides.

Authors:  Mark G Slomiany; Lu Dai; Paul A Bomar; Thomas J Knackstedt; D Alex Kranc; Lauren Tolliver; Bernard L Maria; Bryan P Toole
Journal:  Cancer Res       Date:  2009-05-26       Impact factor: 12.701

7.  Hyaluronan in limb morphogenesis.

Authors:  Yingcui Li; Bryan P Toole; Caroline N Dealy; Robert A Kosher
Journal:  Dev Biol       Date:  2007-02-24       Impact factor: 3.582

8.  Murine hyaluronidase 2 deficiency results in extracellular hyaluronan accumulation and severe cardiopulmonary dysfunction.

Authors:  Biswajit Chowdhury; Richard Hemming; Sabine Hombach-Klonisch; Bruno Flamion; Barbara Triggs-Raine
Journal:  J Biol Chem       Date:  2012-11-21       Impact factor: 5.157

9.  Hyaluronan constitutively regulates activation of COX-2-mediated cell survival activity in intestinal epithelial and colon carcinoma cells.

Authors:  Suniti Misra; Lina M Obeid; Yusuf A Hannun; Susumu Minamisawa; Franklin G Berger; Roger R Markwald; Bryan P Toole; Shibnath Ghatak
Journal:  J Biol Chem       Date:  2008-03-07       Impact factor: 5.157

10.  Molecular ageing in progeroid syndromes: Hutchinson-Gilford progeria syndrome as a model.

Authors:  Henrique Douglas M Coutinho; Vivyanne S Falcão-Silva; Gregório Fernandes Gonçalves; Raphael Batista da Nóbrega
Journal:  Immun Ageing       Date:  2009-04-20       Impact factor: 6.400

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.